Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3038 |
|
Actual shortage: | 235 (8%) | |
Anticipated shortage: | 14 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2780 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-IRBESARTAN | 75MG | TABLET | Resolved | 2017-03-10 | 2017-12-14 | 342 |
APO-PREGABALIN | 75MG | CAPSULE | Resolved | 2017-03-11 | 2017-05-10 | 456 |
APO-PREGABALIN | 75MG | CAPSULE | Resolved | 2017-04-24 | 2017-05-10 | 7704 |
APO-CLOPIDOGREL | 75MG | TABLET | Resolved | 2017-05-04 | 2017-07-22 | 8859 |
APO-DICLO SR | 75MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-05-24 | 2017-09-22 | 11062 |
ACID REDUCER | 75MG | TABLET | Actual shortage | 2017-08-13 | 2017-10-05 | 19042 |
APO-DICLO SR | 75MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-11-27 | 2018-04-17 | 30805 |
APO-DICLO SR | 75MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-07-11 | 2020-01-07 | 55267 |
APO-IRBESARTAN | 75MG | TABLET | Avoided shortage | 2018-07-15 | 2018-08-21 | 55791 |
APO-IRBESARTAN | 75MG | TABLET | Actual shortage | 2018-11-09 | 2018-11-09 | 66534 |
APO-PREGABALIN | 75MG | CAPSULE | Resolved | 2019-12-18 | 2019-12-23 | 101514 |
APO-PREGABALIN | 75MG | CAPSULE | Actual shortage | 2020-01-15 | 2020-01-15 | 103379 |
APO-DABIGATRAN | 75MG | CAPSULE | Resolved | 2020-07-08 | 2020-09-01 | 119756 |
APO-CLOPIDOGREL | 75MG | TABLET | Resolved | 2020-09-22 | 2020-12-30 | 124783 |
APO-CLOPIDOGREL | 75MG | TABLET | Resolved | 2020-10-28 | 2020-12-30 | 127339 |
APO-CLOPIDOGREL | 75MG | TABLET | Resolved | 2021-01-22 | 2021-01-29 | 132349 |
APO-AMITRIPTYLINE | 75MG | TABLET | Resolved | 2021-10-22 | 2022-06-17 | 147812 |
APO-DICLO SR | 75MG | TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE) | Resolved | 2021-11-22 | 2021-12-20 | 149705 |
APO-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2022-09-01 | 2022-09-16 | 168356 |
APO-CLOPIDOGREL | 75MG | TABLET | Resolved | 2023-04-21 | 2023-05-06 | 189994 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-TIMOP | 0.5% | SOLUTION | Discontinued | 2019-01-03 | 2019-01-03 | 70894 |
APO-NITROGLYCERIN | 0.4MG | METERED-DOSE PUMP | Discontinued | 2018-02-26 | 2018-02-26 | 40947 |
APO-NITROGLYCERIN | 0.4MG | METERED-DOSE PUMP | Discontinued | 2019-01-04 | 2019-01-04 | 71189 |
APO-FLUNISOLIDE NASAL SPRAY | 0.25MG | METERED-DOSE PUMP | Discontinued | 2018-02-26 | 2018-02-26 | 40965 |
APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
APO-DICLOFENAC OPHTHALMIC | 0.1% | SOLUTION | Discontinued | 2018-09-07 | 2019-02-13 | 60426 |
APO-CLOBETASOL SPRAY | 0.05% | SPRAY | Discontinued | 2022-09-06 | 2022-09-06 | 168648 |
APO-CLONAZEPAM | .5MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60402 |
APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
APO-CETIRIZINE | Discontinued | 2018-05-31 | 2018-05-31 | 50998 | ||
APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-09-07 | 2018-09-15 | 60241 | ||
APO-CYCLOSPORINE ORAL SOLUTION | Discontinued | 2018-09-07 | 2018-09-15 | 60408 | ||
APO-FAMOTIDINE TAB 20MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60477 | ||
APO-FAMOTIDINE TAB 40MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60480 | ||
APO-FENTANYL MATRIX | Discontinued | 2018-09-07 | 2018-09-15 | 60494 | ||
APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
APO-LATANOPROST-TIMOP | Discontinued | 2018-09-07 | 2018-09-15 | 60572 | ||
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60735 |